Pembrolizumab

7 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Pembrolizumab
Treatment and conditionWhere it standsTrials
Pembrolizumab for carcinosarcomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab for endometrial neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab for leukoplakiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab for neoplasm metastasisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab for neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab for squamous cell carcinoma of head and neckPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2